DK3150222T3 - Stabile immunogene sammensætninger af staphylococcus aureus-antigener - Google Patents
Stabile immunogene sammensætninger af staphylococcus aureus-antigener Download PDFInfo
- Publication number
- DK3150222T3 DK3150222T3 DK16193095.3T DK16193095T DK3150222T3 DK 3150222 T3 DK3150222 T3 DK 3150222T3 DK 16193095 T DK16193095 T DK 16193095T DK 3150222 T3 DK3150222 T3 DK 3150222T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigenes
- staphylococcus aureus
- immunogenic compositions
- stable immunogenic
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426476P | 2010-12-22 | 2010-12-22 | |
| EP11804822.2A EP2654784B1 (en) | 2010-12-22 | 2011-12-21 | Stable immunogenic compositions of staphylococcus aureus antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3150222T3 true DK3150222T3 (da) | 2020-01-27 |
Family
ID=45444677
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11804822.2T DK2654784T3 (da) | 2010-12-22 | 2011-12-21 | Stabile immunogene sammensætninger af staphylococcus aureus-antigener |
| DK16193095.3T DK3150222T3 (da) | 2010-12-22 | 2011-12-21 | Stabile immunogene sammensætninger af staphylococcus aureus-antigener |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11804822.2T DK2654784T3 (da) | 2010-12-22 | 2011-12-21 | Stabile immunogene sammensætninger af staphylococcus aureus-antigener |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20130259896A1 (da) |
| EP (2) | EP2654784B1 (da) |
| JP (1) | JP6097478B2 (da) |
| KR (2) | KR20130114210A (da) |
| CN (1) | CN103826656B (da) |
| AU (1) | AU2011346535B2 (da) |
| BR (1) | BR112013016153A2 (da) |
| CA (1) | CA2819120C (da) |
| DK (2) | DK2654784T3 (da) |
| ES (2) | ES2769425T3 (da) |
| HK (1) | HK1197370A1 (da) |
| HU (2) | HUE047263T2 (da) |
| IL (1) | IL226793B (da) |
| MX (1) | MX350170B (da) |
| PL (2) | PL2654784T3 (da) |
| PT (2) | PT2654784T (da) |
| RU (1) | RU2570730C2 (da) |
| SI (2) | SI3150222T1 (da) |
| WO (1) | WO2012085872A2 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305295B1 (en) | 2004-09-22 | 2015-04-01 | GlaxoSmithKline Biologicals SA | Antibody composition for use in vaccination against staphylococcei |
| PE20142188A1 (es) | 2009-06-22 | 2014-12-29 | Wyeth Llc | Composiciones inmunogenicas de antigenos de staphylococcus aureus |
| JP2012530785A (ja) | 2009-06-22 | 2012-12-06 | ワイス・エルエルシー | 組成物および黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）血清型５および８莢膜多糖コンジュゲート免疫原性組成物を調製するための方法 |
| MX2012013664A (es) * | 2010-06-04 | 2013-01-24 | Wyeth Llc | Formulaciones de vacuna. |
| CN103561762A (zh) * | 2011-03-16 | 2014-02-05 | 明尼苏达大学董事会 | 诱导针对葡萄球菌属中细菌的免疫应答的组合物和方法 |
| GB201310008D0 (en) * | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
| CN106163550A (zh) * | 2013-12-04 | 2016-11-23 | 格林考瓦因有限公司 | 通过大肠杆菌中合成的糖蛋白疫苗预防金黄色葡萄球菌感染 |
| BR112016015422A2 (pt) * | 2013-12-31 | 2017-10-24 | Infectious Disease Res Inst | formulações de vacina de frasco único |
| WO2015155310A1 (en) * | 2014-04-10 | 2015-10-15 | Biotech Tools S.A. | Hsp-free allergen preparation |
| CN110996992A (zh) * | 2017-08-16 | 2020-04-10 | 默沙东公司 | 肺炎球菌缀合物疫苗制剂 |
| GB201802339D0 (en) | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| KR102646145B1 (ko) | 2018-05-31 | 2024-03-11 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물 |
| WO2020027466A1 (ko) | 2018-07-28 | 2020-02-06 | 주식회사 엑소코바이오 | 엑소좀의 동결건조 방법 |
| KR102163806B1 (ko) | 2018-07-30 | 2020-10-07 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물 |
| KR20220140500A (ko) * | 2020-01-13 | 2022-10-18 | 압테보 리서치 앤드 디벨롭먼트 엘엘씨 | 약물 전달 시스템 성분에 대한 치료제 단백질의 흡착을 방지하기 위한 방법 및 조성물 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6008341A (en) | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
| BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
| JPH11514870A (ja) | 1995-10-16 | 1999-12-21 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 新規な唾液結合タンパク質 |
| GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
| GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| JP4486748B2 (ja) | 1997-11-26 | 2010-06-23 | インヒビテツクス，インコーポレイテツド | 黄色ブドウ球菌由来の細胞外マトリックス結合タンパク質 |
| US6680195B1 (en) | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| ATE422368T1 (de) * | 1998-08-31 | 2009-02-15 | Inhibitex Inc | Multikomponenten impfstoffe gegen staphylococcus aureus |
| US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
| US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
| US7384640B1 (en) | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| DE60100814T2 (de) | 2000-06-08 | 2004-07-01 | Intercell Biomedizinische Forschungs- Und Entwicklungs Gmbh | Immunstimulierende oligodeoxynukleotide |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| KR100877258B1 (ko) | 2001-06-07 | 2009-01-12 | 와이어쓰 홀딩스 코포레이션 | 보조제로서 콜레라 홀로톡신의 돌연변이체 형태 |
| CA2449663A1 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| EP2320233A1 (en) | 2001-06-15 | 2011-05-11 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| US9296795B2 (en) | 2003-03-07 | 2016-03-29 | Wyeth Holdings, Llc. | Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| EP1603950A2 (en) | 2003-03-17 | 2005-12-14 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| EP2305295B1 (en) * | 2004-09-22 | 2015-04-01 | GlaxoSmithKline Biologicals SA | Antibody composition for use in vaccination against staphylococcei |
| NZ595178A (en) * | 2006-03-30 | 2013-03-28 | Glaxosmithkline Biolog Sa | Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus |
| AR060188A1 (es) * | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Procedimiento de conjugacion |
| GB0606416D0 (en) * | 2006-03-30 | 2006-05-10 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US20070253985A1 (en) | 2006-04-26 | 2007-11-01 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| CN101808657A (zh) * | 2006-11-07 | 2010-08-18 | 赛诺菲巴斯德生物制剂公司 | 冻干法稳定疫苗 |
| JP5689687B2 (ja) | 2008-03-05 | 2015-03-25 | サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ | アジュバント含有ワクチン組成物の安定化方法 |
| PE20142188A1 (es) * | 2009-06-22 | 2014-12-29 | Wyeth Llc | Composiciones inmunogenicas de antigenos de staphylococcus aureus |
-
2011
- 2011-12-21 ES ES16193095T patent/ES2769425T3/es active Active
- 2011-12-21 BR BR112013016153A patent/BR112013016153A2/pt not_active Application Discontinuation
- 2011-12-21 PT PT118048222T patent/PT2654784T/pt unknown
- 2011-12-21 SI SI201131825T patent/SI3150222T1/sl unknown
- 2011-12-21 EP EP11804822.2A patent/EP2654784B1/en active Active
- 2011-12-21 PL PL11804822T patent/PL2654784T3/pl unknown
- 2011-12-21 CA CA2819120A patent/CA2819120C/en active Active
- 2011-12-21 RU RU2013128277/15A patent/RU2570730C2/ru active IP Right Revival
- 2011-12-21 PL PL16193095T patent/PL3150222T3/pl unknown
- 2011-12-21 HU HUE16193095A patent/HUE047263T2/hu unknown
- 2011-12-21 HU HUE11804822A patent/HUE033072T2/hu unknown
- 2011-12-21 SI SI201131064A patent/SI2654784T1/sl unknown
- 2011-12-21 AU AU2011346535A patent/AU2011346535B2/en active Active
- 2011-12-21 CN CN201180068105.5A patent/CN103826656B/zh active Active
- 2011-12-21 ES ES11804822.2T patent/ES2614815T3/es active Active
- 2011-12-21 DK DK11804822.2T patent/DK2654784T3/da active
- 2011-12-21 MX MX2013006960A patent/MX350170B/es active IP Right Grant
- 2011-12-21 US US13/993,887 patent/US20130259896A1/en not_active Abandoned
- 2011-12-21 WO PCT/IB2011/055883 patent/WO2012085872A2/en active Application Filing
- 2011-12-21 KR KR1020137018851A patent/KR20130114210A/ko active Application Filing
- 2011-12-21 PT PT161930953T patent/PT3150222T/pt unknown
- 2011-12-21 EP EP16193095.3A patent/EP3150222B1/en active Active
- 2011-12-21 KR KR1020157031951A patent/KR101808398B1/ko active IP Right Grant
- 2011-12-21 DK DK16193095.3T patent/DK3150222T3/da active
- 2011-12-22 JP JP2011280781A patent/JP6097478B2/ja active Active
-
2013
- 2013-06-06 IL IL226793A patent/IL226793B/en active IP Right Grant
-
2014
- 2014-10-30 HK HK14110911.9A patent/HK1197370A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3150222T3 (da) | Stabile immunogene sammensætninger af staphylococcus aureus-antigener | |
| DK2892550T3 (da) | Stabile vandige formuleringer af adalimumab | |
| DK2567524T3 (da) | Reduktion af protokolspild | |
| DK2603232T3 (da) | Stabile formuleringer af linaclotid | |
| DK2528602T4 (da) | Formuleringer af bendamustin | |
| DK3725778T3 (da) | Formuleringer af enzalutamid | |
| DK3336097T3 (da) | Fremstilling af ikke-krystallinsk obeticholsyre | |
| DK3156056T3 (da) | Farmaceutiske sammensætninger der består af sorbitanestere | |
| DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
| DK2872152T3 (da) | Acellulære pro-tolerogene sammensætninger til behandling/forebyggelse af transplantatafstødning | |
| CO6950492A2 (es) | Composiciones plaguicidas estables | |
| CO6970594A2 (es) | Composiciones hemostáticas | |
| CO6930368A2 (es) | Composiciones de yodo-povidona estable | |
| DK3513803T3 (da) | Hæmostatiske sammensætninger | |
| DK2419096T3 (da) | Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre | |
| DK2633006T3 (da) | Fremstilling af fornybart bio-destillat | |
| DK2822568T3 (da) | Anvendelser af caseinsammensætninger | |
| DK3106150T3 (da) | Forbedrede farmaceutiske sammensætninger af pimobendan | |
| DK2800572T3 (da) | Sammensætning af ellagitannin-rige ekstrakter | |
| DK2919777T3 (da) | Transmukosal afgivelse af tocotrienol | |
| DK2931313T3 (da) | Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer | |
| DK3409686T3 (da) | Sammensætning omfattende en blanding af cd95-fc-isoformer | |
| DK2858989T3 (da) | Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil | |
| DK2925338T3 (da) | Frysetørret formulering af tat-nr2b9c | |
| DK2934134T3 (da) | Anvendelser af acetylsalicylsyreinhalering |